Literature DB >> 3370022

Fibronectin stimulates macrophage uptake of low density lipoprotein-heparin-collagen complexes.

D J Falcone1, B G Salisbury.   

Abstract

In this study, we investigated whether fibronectin will enhance macrophage uptake of particulate complexes of low density lipoproteins (LDL), heparin, and fibrillar collagen and whether fibronectin's opsonic effect could be modulated by the heparin component in these model matrices. We isolated a heparin fraction (HepFn) based on its affinity to fibronectin. HepFn appeared more charged than unfractionated heparin, as evidenced by enhanced electrophoretic mobility and ability to effect a cathodic shift in the electrophoretic migration of fibronectin. HepFn lacked the smaller molecular weight species present in unfractionated heparin. Macrophage endocytosis of LDL-heparin-collagen complexes, as evidenced by the intracellular accumulation of LDL-derived cholesteryl esters and endogenously synthesized cholesteryl esters, was enhanced by fibronectin. When LDL matrix complexes were prepared with HepFn, fibronectin's opsonic properties were significantly enhanced. F(ab)2 fragments of anti-fibronectin, capable of inhibiting fibronectin's opsonization of gelatin-derivatized latex particles, inhibited the fibronectin-dependent stimulation of cholesteryl ester synthesis by macrophages exposed to LDL-HepFn-collagen complexes. Thus, fibronectin stimulates macrophage endocytosis of LDL matrix complexes. The affinity of the constituent glycosaminoglycan for fibronectin is important in the regulation of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370022     DOI: 10.1161/01.atv.8.3.263

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  7 in total

1.  Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages.

Authors:  P Vijayagopal
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

2.  Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.

Authors:  Prakash Doddapattar; Chintan Gandhi; Prem Prakash; Nirav Dhanesha; Isabella M Grumbach; Michael E Dailey; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-01       Impact factor: 8.311

3.  Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages.

Authors:  Marcos Andre Rodrigues da Costa Santos; Jhenifer Santos Dos Reis; Carlos Antonio do Nascimento Santos; Kelli Monteiro da Costa; Pedro Marçal Barcelos; Karen Queiroz de Oliveira Francisco; Pedro Antônio Guimarães Notaroberto Barbosa; Emanuelle Damasceno Souza da Silva; Celio Geraldo Freire-de-Lima; Alexandre Morrot; Debora Decote-Ricardo; Israel Diniz-Lima; Jose Osvaldo Previato; Lucia Mendonca-Previato; Leonardo Marques da Fonseca; Leonardo Freire-de-Lima
Journal:  Immunol Res       Date:  2022-10-05       Impact factor: 4.505

4.  Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions.

Authors:  P Vijayagopal; S R Srinivasan; J H Xu; E R Dalferes; B Radhakrishnamurthy; G S Berenson
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.

Authors:  E M Salonen; M Jauhiainen; L Zardi; A Vaheri; C Ehnholm
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

6.  Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.

Authors:  T A McCaffrey; D J Falcone; C F Brayton; L A Agarwal; F G Welt; B B Weksler
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

Review 7.  Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism.

Authors:  Joshua A Dubland; Gordon A Francis
Journal:  Front Cell Dev Biol       Date:  2015-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.